nodular lymphocyte-predominant hodgkin lymphoma
Published 3 years ago • 1.8K plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:25
differences between nlphl and classical hl & promising treatment approaches for nlphl
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
1:30
investigating the prognostic impact of immunoarchitectural patterns in nlphl
-
7:50
nodular sclerosis hodgkin lymphoma - histopathology
-
18:52
medical school pathology: hodgkin lymphoma
-
18:00
how should we manage lymphocyte predominant hodgkin lymphoma?
-
1:37
dr. cheah on treatment for nodular lymphocyte predominant hodgkin lymphoma
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
2:39
new findings and challenges in the use of immunotherapy in hodgkin lymphoma
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
0:55
intracranial disease in hodgkin lymphoma: a case study
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:05
nodular lymphocyte predominant hodgkin lymphoma
-
1:03
what’s on the horizon for hodgkin lymphoma?
-
1:43
keynote-667: pembrolizumab for children and young adults with classical hodgkin lymphoma
-
1:27
challenges in understanding the genomic landscape of hodgkin lymphoma
-
4:04
molecular characterization of classical hodgkin lymphoma
-
1:14
are biomarkers the future in non-hodgkin lymphoma?
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:10
avenue: avelumab for classical hodgkin lymphoma